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Objective To investigate interstrain relatedness of TEM-24 -producing Enterobacter aerogenes clinical strains
isolated between1993 and1998 in10 French hospitals from nine areas by pulsed-¢eld gel electrophoresis
(PFGE) and plasmid patterns.
Methods FifteenTEM-24-producing strains and a set of16 control strains having various other antibiotic
resistance phenotypes were genotyped by PFGE. PlasmidDNA fromTEM-24-producing strains and
transconjugants was analyzed.
Results Analysis ofXbaI macrorestriction patterns revealed onlyminor variations, and showed that all 15
TEM-24-producing strains were closely related. Some isolates originating fromdistant areas had
indistinguishable patterns.According to their clustering correlation coe¤cients, they were also genomically
distant from the control strains.Two plasmid patterns were observed inTEM-24 -producing strains, one of
them in13 of the strains. Large plasmids of 85  kb encodingTEM-24 b -lactamasewere present in all isolates
and, in all except one strain, could be transferredwith high frequency byconjugation.
Conclusions These results con¢rm that the spread of theTEM-24 extended-spectrum b-lactamase in
Francewas essentially due to the dissemination of a single clone.
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I N T R O D U C T I O N
Enterobacter aerogenes has recently emerged as an important hos-
pital pathogen [1,2]. In this species, as in other b-lactamase-
inducible Gram-negative bacilli, resistance to broad-spectrum
cephalosporins is due mostly to stable de-repressed mutants
overproducing their chromosomal enzyme; this may be
selected during therapy, and can spread within the hospital
environment [3,4]. Other mechanisms of b-lactam resistance
have been described in Enterobacter aerogenes; they include plas-
mid-mediated b-lactamases, and the diminution of membrane
permeability due to lack of a porin combined with high-level
constitutive b-lactamase production leading to imipenem
resistance [5^7]. Detection of extended-spectrum b-lactamase
(ESBL) production in Enterobacter aerogenes can be di¤cult
when chromosomal cephalosporinase is overproduced, so ren-
dering the organisms resistant to all b-lactam antibiotics
except the carbapenems and cefepime or cefpirome [8]. Out-
breaks of multiresistant Enterobacter aerogenes have been
reported in several countries, especially among patients in
intensive care units [3,9,10]. These organisms have acquired
large plasmids encoding a variety of ESBLs, includingTEM-
3, TEM-10, TEM-12, TEM-24 and TEM-26 [10^12]. In
France, Enterobacter aerogenes strains producingTEM-24 ESBL
have been found to be responsible for several outbreaks of
nosocomial infections [13,14]. Our own hospital has experi-
enced two outbreaks caused by such strains [15].
The epidemiology of ESBL-producing Enterobacteriaceae
is complex; it involves the spread of self-transferable plasmids
and the transposition of resistance genes among di¡erent plas-
mids, as well as clonal strain spread [16]. In France, for exam-
ple,TEM-3 b-lactamase became widespread in the late 1980s,
mainly because of the spread of a plasmid carrying its gene [17,
18]. Inter-hospital transmission of ESBL-producing Entero-
bacteriaceae has also been seen in the USA [19,20].The short-
comings of phenotypically based typing methods have led to
the development of methods based on themicrobial genotype,
sominimizing problems with typing and reproducibility [21].
ORIGINAL ARTICLE
= 2000 Copyright by the European Society of Clinical Microbiology and Infectious Diseases
Corresponding author and reprint requests: C. Branger, Laboratoire de Micro-
biologie, Hoª pital Beaujon, 100 Boulevard du Ge¨ne¨ral Leclerc, 92110, Clichy,
France
Tel:    33140 87 54 54
Fax:    33140 87 05 50
E-mail: catherine.branger@bjn.ap-hop-paris.fr
Among them, PCR-mediated procedures such as RAPD or
Rep-PCR, which can be performed rapidly and easily, have
been used successfully for identifying the short-term spread of
bacterial strains [9,22]. However, standardization and inter-
pretation are not always easy.With these techniques,TEM-24-
producing Enterobacter aerogenes strains isolated in France dur-
ing a 6-month period showed similar characteristics [23].
Pulsed-¢eld gel electrophoresis (PFGE) of genomic macrores-
triction fragments, with its high reproducibility and discrimi-
natory power, has been widely applied for subtyping various
pathogens. It allows interstrain relatedness to be assessed, a
characteristic which is useful for tracing the evolution of epi-
demic strains over extended periods [16,24].
This study was designed to use macrorestriction ¢nger-
printing of genomic DNA and plasmid typing to investigate
the clonal relatedness of TEM-24-producing Enterobacter aero-
genes strains isolated in hospitals from various areas of France
and to assess the genomic evolution of strains obtained over a
5-year period. They were also compared to a set of control
strains of other antibiotic resistance phenotypes.
M A T E R I A L S A N D M E T H O D S
Bacterial strains
We analyzed 15 clinical isolates of Enterobacter aerogenes produ-
cing TEM-24 b -lactamase, all of which were isolated in
France between 1993 and 1998 (Table  1). They were selected
to be representative of a broad geographic area. Four were
isolated in the Paris area (Clichy and Pontoise) and 11 were
isolated from eight other areas (Bordeaux, Colmar, Dieppe,
Dijon, Marseille, Saint Calais, Saint Etienne and Strasbourg).
One isolate was studied from each of seven hospitals; from the
three other hospitals, two to three isolates were studied. A
control group of 16 Enterobacter aerogenes isolates was also
included for study by PFGE.These were collected during the
same period from four areas (Clichy, Saint Calais, Dieppe and
Brest). Five produced a putative SHV-4 ESBL (SHV pheno-
type), six had high-level production of chromosomal cepha-
losporinase (Case phenotype), and ¢ve were of wild
phenotype. All the isolates were identi¢ed with the API 20E
system (bioMe¨rieux,Marcy l'e¨toile, France).
Antibiotic susceptibility testing
Susceptibility to antimicrobial agents was tested by the disk
di¡usion method on Mueller^Hinton agar (Sano¢ Diagnos-
tics Pasteur, Marnes la Coquette, France) with commercially
available disks according to the guidelines of the Antibiogram
Committee of the French Society for Microbiology [25].
These agents were amoxycillin, amoxycillin^clavulanate,
ticarcillin, ticarcillin^clavulanate, piperacillin, piperacillin^
tazobactam, cefotaxime, ceftazidime, cefpirome, imipenem,
aztreonam, gentamicin, tobramycin, kanamycin, strepto-
mycin, tetracycline, netilmicin, amikacin, spectinomycin,
chloramphenicol, trimethoprim^sulfamethoxazole, and
pe£oxacin. Disks of apramycin, 20 -N-ethyl-netilmicin and 60 -
N-ethyl-netilmicin (Schering-Plough Research Institute,
Kenilworth, NJ, USA) were also tested. ESBLs were detected
Table  1 Relevant characteristics of the 15 Enterobacter aerogenes strains producing TEM-24 b-lactamase
Strain
Date of isolation
(month/year) City
Resistance co-transferred
with TEM-24 b-lactamase
pI of
ESBL
Plasmid
pattern
XbaI
pattern
4 9/93 Bordeaux Sm Sp Km Tm Nt Am Tc Tp 6.5 P2 1d
8 10/93 Bordeaux Sm Sp Km Tm Nt Am Tc Cm Tp 6.5 P2 1g
15 10/93 Dijon No transconjugant 6.5 P2 1i
13 1/96 Clichy Sm Sp Km Tm Nt Am Cm Tp 6.5 P2 1k
10 2/96 Clichy Sm Sp Km Tm Nt Am Tc Cm Tp 6.5 P2 1i
12 3/96 Pontoise Sm Sp Km Tm Nt Am Tc Cm Tp 6.5 P2 1i
6 5/96 Clichy Sm Sp Km Tm Nt Am Tc Cm Tp 6.5 P2 1f
3 8/96 Marseille Sm Sp Km Tm Nt Am Tc Cm Tp 6.5 P2 1c
5 1/97 St Calais Sm Sp Km Tm Nt Am Tc Cm Tp 6.5 P2 1e
7 5/97 St Etienne Sm Sp Km Tm Nt Am Tc Cm Tp 6.5 P1 1f
9 7/97 St Etienne Sm Sp Km Tm Nt Am Tc Cm Tp 6.5 P2 1  h
1 9/97 St Etienne Sm Sp Km Tm Nt Am Tc Cm Tp 6.5 P1 1a
14 12/97 Dieppe Sm Sp Km Tm Nt Am Tc Cm Tp 6.5 P2 1j
2 2/98 Colmar Sm Sp Km Tm Nt Am Tc Cm Tp 6.5 P2 1b
11 3/98 Strasbourg Sm Sp Km Tm Nt Am Tc Cm Tp 6.5 P2 1i
Sm, streptomycin; Sp, spectinomycin; Km, kanamycin; Tm, tobramycin; Nt, netilmicin; Am, amikacin; Tc, tetracycline; Cm, chloramphenicol;
Tp, trimethoprim.
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by the double-disk synergy test with a 30-mm spacing
between the disks as previously described [17], and also with a
20-mm spacing. The synergy test was also carried out on
Mueller^Hinton agar containing 500  mg/L of cloxacillin
[26]. A disk of ticarcillin plus clavulanic acid was used with
disks of ceftazidime, cefotaxime, aztreonam, ceftriaxone, cef-
pirome and cefepime. Minimal inhibitory concentrations
(MICs) of b-lactams were determined by the Etest technique
(AB Biodisk, Solna, Sweden) as recommended by the manu-
facturer. MICs of cefotaxime and ceftazidime were also deter-
mined in the presence of 500  mg/L of cloxacillin [26].
Iso-electric focusing of b-lactamases
Analytical iso-electric focusing was performed with crude
cell sonic extracts on pH  3.5^9.5 polyacrylamide gel (Pharma-
cia Biotech, Orsay, France) [8,27]. b-Lactamase activity was
detected by an iodometric method with benzylpenicillin (100  
mg/L) or ceftriaxone (200  mg/L gel) as substrates [27]. b-Lac-
tamases with known pIs (TEM-1, 5.4;TEM-3, 6.3; SHV-1, 7.6;
SHV-4, 7.8; SHV-5, 8.2) were run in parallel with the
extracts.
TEM-24 PCR analysis and sequencing
Total cellular DNA was extracted with Instagen (BioRad,
Ivry sur Seine, France), as recommended by the manufacturer.
Primer 1 (50 -ATGAGTATTCAACATTTGCG-30) and primer
2 (50 -CTGACAGTTACCAATGCTTA-30) described by
Rasheed et al [28] were used for the ampli¢cation of the entire
blaTEM gene. PrimerA (50 -GGGCAAGAGCAACTCGGT-30)
and primer B (50 -AGACCCACGCTTACCGGT-30)
described by Neuwirth et al [13] were used for speci¢c ampli-
¢cation of the blaTEM-24 gene. Ampli¢cation reactions were
performed in a total volume of 50  mL containing 10  mL of
DNA template, 200  mM (each) deoxynucloside triphosphate,
0.5  mM primer and 1  U ofTaq polymerase in 1    PCR bu¡er
(RocheMolecular Biochemicals, Meylan, France).The ampli-
¢cation program started with denaturation for 5  min at 94  C.
The 35 subsequent cycles of ampli¢cation consisted of dena-
turation for 1  min at 94  C, annealing for 1  min at 57  C and
extension for 1  min at 72  C.Ten microliters of PCRproducts
was electrophoresed in a 1% agarose gel and stained with ethi-
dium bromide (0.5  mg/L). PCRproducts, generated with pri-
mers 1 and 2 from DNA extracts of strains 1, 6 and 13, were
used for direct sequencing.This was performed with an auto-
matic sequencer (377, ABI Prism, Perkin-Elmer, Roissy,
France) by GenomeExpress, Paris, France.
PFGE of macrorestriction fragments and comparative
analysis of banding patterns
The preparation of DNA and the digestion with XbaI were as
described previously [29]. Fragments in 0.5TBE bu¡er, pH  
8.0, at 12  C were separated by a contour-clamped homoge-
neous electric ¢eld (CHEF-DRII system, BioRad) at 200  V
for 18  h with pulse times of 6^15  s for 5  h and 23^40  s for 13  h.
Concatameric bacteriophage lambda DNA molecules (48.5  
kb; BioRad) were used as a size standard. To estimate the
degree of relatedness between isolates, a similarity matrix was
created using the band-based Dice similarity coe¤cient [30].
Clustering correlation coe¤cients were calculated by the
unweighted pair-group method using average linkages
(UPGMA) determined with GelCompar software (Applied
Maths, Kortrijk, Belgium).
Transfer of resistance to oxyimino-b-lactams
Escherichia coli K-12  J53-2 resistant to rifampicin was used as a
recipient for conjugation of the plasmids encoding theTEM-
24 ESBL. Transconjugants were selected on plates containing
Mueller^Hinton agar supplemented with ceftazidime (4  mg/
L) and rifampicin (250  mg/L). The frequency of transfer was
expressed relative to the number of donor cells [31].
Plasmid analysis
Plasmid DNA from bacterial strains and transconjugant
Escherichia coli was extracted and puri¢ed with ion exchange
cartridges (Nucleobond AX, Macherey-Nagel, Hoerdt,
France) according to the manufacturer's instruction, and
DNAwas analyzed after separation on 0.7% agarose gel. Plas-
mid pAFF2 with a molecular size of 85^90  kb from Escherichia
coli BM 694 was used as standard [32]. Puri¢ed plasmid DNA
from transconjugant Escherichia coli for isolates 2 and 12 was
digested with restriction enzyme PstI by using the bu¡er and
reaction conditions recommended by the manufacturer
(Roche Molecular Biochemicals) and electrophoresed on a
0.8% agarose gel.
R E S U L T S
Antimicrobial susceptibility
By disk agar di¡usion, all the TEM-24 -producing ESBL
Enterobacter aerogenes isolates were resistant to all b-lactams
tested except imipenem.TheMICs of ceftazidimewere higher
than those of cefotaxime (Table  2). In the presence of 500  mg/
L of cloxacillin, which inhibits cephalosporinase activity, the
MICs of these two cephalosporins were decreased (Table  2).
Although the presence of clavulanic acid lowered the MICs of
ticarcillin and piperacillin, susceptibility of the isolates to
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these antibiotics was not fully restored. These results showed
that in association with the production of theTEM-24 ESBL,
the chromosomal Bush group 1 b-lactamase was overpro-
duced. When disks were placed 30  mm apart, a synergistic
e¡ect was observed between ticarcillin^clavulanic acid and
cefepime or cefpirome, but not between ticarcillin^clavulanic
acid and ceftazidime, cefotaxime or aztreonam. For these last
three antibiotics, a synergistic e¡ect with ticarcillin^clavula-
nic acid was obtained when tested on Mueller^Hinton agar
containing 500  mg/L cloxacillin, or when disks were placed
20  mm apart. In addition to the b-lactam resistance, all the
TEM-24-producing isolates were resistant to pe£oxacin, tet-
racycline, chloramphenicol, trimethoprim and all the amino-
glycosides tested except gentamicin, apramycin and 60 -N-
ethyl-netilmicin. This aminoglycoside spectrum of activity
suggests that all the isolates produced two types of modifying
enzyme: an AAC(60)-1 (resistance to tobramycin, netilmicin,
20 -N-ethyl-netilmicin, amikacin) and an ANT (30 0)-1 (resis-
tance to streptomycin and spectinomycin).
Iso-electric focusing
All 15 isolates of Enterobacter aerogenes producing a putative
TEM-24 ESBL and the ¢ve control isolates producing a puta-
tive SHV-4 ESBL were analyzed for their b-lactamase con-
tent. With ceftriaxone as substrate, all the isolates had two
bands of b-lactamase activity.The ¢rst bandwas of pI 8.3, cor-
responding to de-repressed chromosomal cephalosporinase.
The second band was for 15 isolates of pI 6.5 (putative TEM-
24) and for ¢ve isolates of pI 7.8 (putative SHV-4). No addi-
tional band of activity was detected with benzylpenicillin as
substrate.
Identi®cation of encoding gene by TEM-24-speci®c PCR and
DNA sequencing
By usingTEM-24-speci¢c primers, a DNA fragment of 476  
bp was ampli¢ed from total DNA samples of all the isolates
producing an enzyme of pI 6.5. No ampli¢cation fragment
was present in the total DNA sample of the ¢ve control isolates
producing an enzyme of pI 7.8, or in the six control isolates
with a Case phenotype. Nucleotide sequencing of the blaTEM
PCRproducts of strains 1, 6 and13 producing an enzyme of pI
6.5 showed that they represent ampli¢ed genes coding for the
TEM-24 enzyme as described by Chanal et al [33], except that
one silentmutation (T 6824C)was found.
PFGE analysis
After digestion with XbaI, Enterobacter aerogenes DNA gave 13^
19 fragments of 30^850  kb (Figure 1). The patterns obtained
for theTEM-24 -producing isolates di¡ered byonly1^5 bands
and had similarity coe¤cients>88%.They clustered into the
same major pattern, number 1 (Figure 2). Another 15 separate
major patterns were found for the 16 control isolates. All the
major patterns were distinct, showing no more than 38^70%
similarities (Figure 2). Indistinguishable patterns were
observed for several TEM-24-producing isolates originating
from distant areas: pattern 1f for isolates 6 and 7, and pattern 1i
for isolates 10, 11, 12 and 15. The two isolates responsible for
two episodes of outbreak in our hospital di¡ered by three
bands (patterns 1i and 1f). All the control isolates, except two
of SHVphenotype, had di¡erent patterns.These two isolates,
although isolated from distant areas, were of the same major
pattern, 4, and di¡ered by only one band (patterns 4a and 4b)
(Figure 2).
Table  2 Resistance pattern to b-lactam antibiotics of the Enterobacter aerogenes strains studied
MIC range (mg/L)
b-Lactams TEM-24a Caseb Wildc
Cefotaxime 4±32 2±16 0.06±0.25
Cefotaxime  cloxacillin (500  mg/L) 2±8 0.064 <  0.016 ÿ0.064
Ceftazidime 64 to >256 8±16 0.25±0.5
Ceftazidime  cloxacillin (500  mg/L) 32±128 0.5±2 0.03±0.5
Aztreonam 32±128 1.5±6 0.023±0.125
Cefepime 2±8 0.19±1 0.016±0.047
Cefpirome 2±8 0.25±2 0.023±0.125
Ticarcillin >  256 64 to >128 2±8
Ticarcillin  clavulanic acid 64±128 64 to >128 2±8
Piperacillin 128±256 16 to >128 4±8
Piperacillin  clavulanic acid 32±128 16 to >128 2±8
aTEM-24, TEM-24-producing isolates. bCase, cephalosporinase-producing isolates. cWild phenotype isolates.
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Transfer of oxyimino-b-lactam resistance
Conjugation experiments were carried out on the Enterobacter
aerogenes isolates producingTEM-24 ESBL. Oxyimino-b-lac-
tam antibiotic resistance was transferred to Escherichia coliK-12
with high frequency (10ÿ3ÿ10ÿ4) in all isolates except one
(isolate 15). Some resistance markers were also co-transferred
(Table  1): aminoglycosides and trimethoprim in all isolates;
tetracycline and chloramphenicol in13 isolates (Table  1).
Plasmid analysis
Two di¡erent plasmid patterns were observed among the
TEM-24-producing isolates (Figure 3,Table  1). Pattern P2 was
common to 13 isolates and corresponded to the presence of
two plasmids. In the two other isolates, in addition to the large
plasmid, two plasmid bands, with low molecular weight,
were detected. In Escherichia coli transconjugants, acquisition of
resistance to oxyimino-b-lactam antibiotics was correlated
with the transfer of a large plasmid whose molecular mass was
estimated to be 85^90  kb after restrictionwith PstI (Figure 4).
D I S C U S S I O N
Nosocomial infections with Enterobacteriaceae expressing
ESBLs have become widespread in clinical medicine [34, >35].
It is important to detect Enterobacter strains producing ESBLs
in a clinical laboratory, and to di¡erentiate them from de-
repressed mutants, because they can be responsible for the
spread of resistance genes in hospitals. However, di¤culties
have been noted in trying to detect ESBL production in Enter-
obacter over-expressing chromosomally mediated cephalos-
porinase [36]. In our study, the easiest detection conditions by
double disk synergy were with disks of cefepime and amoxy-
cillin^clavulanic acid placed 30  mmapart.
Figure  1 PFGE of XbaI-digested DNA from 20 Enterobacter
aerogenes isolates. Lanes 1, 5, 13 and 20: pattern 1f. Lane 2:
pattern 1i. Lane 3: pattern 1j. Lane 4: pattern 1b. Lane 6: pat-
tern 1a. Lane 7: pattern 1e. Lane 8: pattern 1  h. Lane 9: pattern
1k. Lane 10: pattern 1c. Lane 11: pattern 1d. Lane 12: pattern
1g. Lane 14: pattern 2. Lane 15: pattern 7. Lane 16: pattern 4b.
Lane 17: pattern 8. Lane 18: pattern 16. Lane 19: pattern 5.
Lane 21: bacteriophage lambda DNA concatemers (BioRad).
Figure  2 Classi®cation and schematic representation of the
XbaI patterns of the Enterobacter aerogenes isolates. The b-
lactam phenotypes corresponding to the XbaI patterns are
indicated: production of ESBLs (SHV or TEM-24); over-produc-
tion of the chromosomal cephalosporinase alone (Case); or
wild phenotype (Wild).
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Strains of Enterobacter aerogenes producing TEM-24 ESBL
have been reported in several areas of France since 1993, and
have been responsible for several outbreaks [13^15]. Using
AP-PCR as a typing method, Bosi et al suggested that such
strains were closely related [23]. Genetic typing showed that
strains which undergo short-term spread during an outbreak
accumulate a limited number of genetic variations [24].
Therefore, it would be expected that in a nationwide spread of
bacterial strains over a longer period, an increasing amount of
polymorphism would be detected. To evaluate the poly-
morphism of TEM-24-producing strains of Enterobacter aero-
genes collected over 5  years from hospitals in distant areas in
France, we chose PFGE as a molecular tool because it has good
discriminatory power and allows a quantitative assessment of
genomic relatedness to be made. In the present study, PFGE
gave consistent results. Enterobacter aerogenes control isolates,
with diverse antibiotic resistance pro¢les (wild phenotype,
case phenotype, SHV phenotype), exhibited a high degree of
polymorphism, so con¢rming heterogeneity within the Enter-
obacter aerogenes species. All the 15 TEM-24-producing isolates
had very similarXbaI patterns (pattern 1), di¡ering by nomore
than ¢ve fragments. Using computer analysis, all these pat-
terns clustered at greater than 88% similarity.Theywere likely
to represent genotypic variants of the same clone which, over
time, underwent minor rearrangements. Four isolates origi-
nating from four distant areas collected 5  years apart had indis-
tinguishableXbaI patterns. No pattern other than pattern1was
found among the TEM-24-producing isolates, and this pat-
tern was not seen among the control isolates. Even more sur-
prising was the fact that the TEM-24 -encoding plasmid was
found to be transferable at high frequency during conjugation.
These observations suggest that strains of pattern1are strongly
associatedwith theTEM-24-encoding plasmid.
The epidemiology of ESBL is complex, and DNA ¢nger-
printingmethods for analyzing both the bacterial genome and
theRplasmid are required.The DNAcomposition of antibio-
tic resistance plasmids may change through various transfers,
or because of the acquisition or loss of resistance-encoding
transposons. As a result, epidemiologically related isolates
may exhibit di¡ering plasmid pro¢les which have evolved
under antibiotic pressure.Variations of plasmid pro¢les during
an outbreak or during longitudinal analysis have been docu-
mented [37]. In our study it was remarkable that all but two of
theTEM-24-producing isolates had the same plasmid pro¢le.
A plasmid of about 85  kb encodingTEM-24 b -lactamase was
easily transferred to Escherichia coli in all except one of the 15
isolates. The plasmid co-transferred the same resistance mar-
kers, except for two isolates in which tetracycline or chloram-
phenicol resistance was not transferred. Antibiotic resistance
patterns are in£uenced by mutation, which may be selected
under antibiotic pressure. Further experiments using restric-
Figure  3 Plasmid pattern of TEM-24-producing Enterobacter
aerogenes and transconjugant. Lane 1: molecular mass marker
X (Roche Molecular Biochemicals). Lane 2: pAFF2 (SHV-5).
Lane 3: representative transconjugant. Lanes 4, 5 and 7: pat-
tern P2. Lane 6: pattern P1.
Figure  4 PstI ®ngerprint of plasmids encoding TEM-24 b-lacta-
mase isolated from the Escherichia coli transconjugants. Lane
1: plasmid from Enterobacter aerogenes 2. Lane 2: plasmid
from Enterobacter aerogenes 12. Lane 3: molecular weight
marker X (Roche Molecular Biochemicals). Lane 4: phage
lambda digested by HindIII (Roche Molecular Biochemicals).
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tion endonuclease analysis would be useful to compare the sta-
bility of the plasmid among the isolates.
Di¡erent epidemiologic patterns in the dissemination of
ESBL genes have been observed. Prodinger et al found that
several SHV-5-producing Klebsiella pneumoniae outbreak
strains were linked by the same R plasmid [38]. Similarly,
molecular analysis has demonstrated that the spread of the
TEM-3 bla gene among Enterobacteriaceae in France involved
a single epidemic plasmid that underwent minor modi¢cation
[18]. By contrast, the dissemination of the SHV-4 bla gene in
French hospitals occurred via a single K. pneumoniae strain
[37]. Likewise,TEM-24 b -lactamase among isolates of Entero-
bacter aerogenes in France has beenmainly the result of the disse-
mination of a single strain. PFGEmeasured only limited or no
genetic variations of this strain over-time, suggesting that its
genome is stable. It has been demonstrated that acquisition of
virulence factors, antibiotic resistance or resistance to environ-
mental stress favors the development and spread of pathogenic
strains [1,39]. This observation makes it hard to di¡erentiate
strains during epidemiologic studies. In our study, it was di¤-
cult to decide if the second outbreak in our hospital was due to
the reintroduction of a TEM-24 -producing strain, or to the
¢rst epidemic strain having persisted in an undetected reser-
voir. Epidemiologic surveillance or the investigation of bac-
terial outbreaks should take into account the extent of
geographic spread.
Because the hospitals from which the isolates originated
are located so far apart in France, only the transfer of patients
between hospitals can account for the spread of TEM-24-pro-
ducing Enterobacter aerogenes strains at a national level. This
emphasizes the importance of following guidelines for infec-
tion control measures, such as early detection of colonized
patients and the use of standard contact isolation precautions.
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